Huiru Cui Selected Research

Schizophrenia (Dementia Praecox)

8/2023	The effect of initial antipsychotic treatment on hippocampal and amygdalar volume in first-episode schizophrenia is influenced by age.
4/2023	Spatial and Temporal Abnormalities of Spontaneous Fixational Saccades and Their Correlates With Positive and Cognitive Symptoms in Schizophrenia.
1/2022	Functional reconfiguration of cerebellum-cerebral neural loop in schizophrenia following electroconvulsive therapy.
1/2022	Thalamo-hippocampal dysconnectivity is associated with serum cholesterol level in drug-naïve patients with first-episode schizophrenia.
10/2021	The effects of antipsychotics on interactions of dynamic functional connectivity in the triple-network in first episode schizophrenia.
8/2021	Effect of DAOA genetic variation on white matter alteration in corpus callosum in patients with first-episode schizophrenia.
1/2021	Temporal Dynamics in Degree Centrality of Brain Functional Connectome in First-Episode Schizophrenia with Different Short-Term Treatment Responses: A Longitudinal Study.
12/2020	P300 as an index of transition to psychosis and of remission: Data from a clinical high risk for psychosis study and review of literature.
1/2018	Increased resting-state global functional connectivity density of default mode network in schizophrenia subjects treated with electroconvulsive therapy.
12/2016	Effect of Clonazepam Co-Administered with Clozapine on the Serum Clozapine and Norclozapine Concentration of Patients with Schizophrenia: A Retrospective Survey.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Huiru Cui Research Topics

Disease

14	Schizophrenia (Dementia Praecox) 08/2023 - 10/2012
5	Psychotic Disorders (Schizoaffective Disorder) 01/2023 - 12/2014
1	Major Depressive Disorder (Major Depressive Disorders) 12/2023
1	Dyslipidemias (Dyslipidemia) 01/2022
1	Cognitive Dysfunction 01/2020
1	Anxiety Disorders (Anxiety Disorder) 01/2019
1	Dementia (Dementias) 02/2013

Drug/Important Bio-Agent (IBA)

6	Antipsychotic Agents (Antipsychotics)IBA 08/2023 - 04/2016
4	Biomarkers (Surrogate Marker)IBA 04/2023 - 10/2012
2	gamma-Aminobutyric Acid (GABA)IBA 01/2016 - 12/2014
1	salicylhydroxamic acid (SHAM)IBA 01/2023
1	1-stearoyl-2-arachidonoylglycerolIBA 01/2022
1	CholesterolIBA 01/2022
1	Polytetrafluoroethylene (Teflon)FDA Link 01/2022
1	D-Amino-Acid Oxidase (D-Amino Acid Dehydrogenase)IBA 08/2021
1	Clonazepam (Rivotril)FDA LinkGeneric 12/2016
1	Clozapine (Clozaril)FDA LinkGeneric 12/2016
1	norclozapineIBA 12/2016
1	Glutamic Acid (Glutamate)FDA Link 01/2016
1	Aminobutyrates (Aminobutyric Acid)IBA 01/2016
1	Neurotransmitter Agents (Neurotransmitter)IBA 12/2014
1	Ginkgo biloba extract (Rokan)IBA 02/2013
1	Brain-Derived Neurotrophic Factor (BDNF)IBA 10/2012

Therapy/Procedure

4	Transcranial Magnetic Stimulation 12/2023 - 01/2019
1	Therapeutics 01/2018